US gives nod to Pfizer Covid vaccine for children aged 5-11
By MYBRANDBOOK
The United States has authorized the Pfizer Covid vaccine for children aged five-to-11, paving the way for 28 million young Americans to soon get immunized. The decision came after a high-level medical panel advising the government this week endorsed the shots, ruling that the known benefits outweighed the risks of side-effects.
"As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today's authorization," said acting Food and Drug Administration Chief Janet Woodcock in a statement.
The vaccine rollout should begin in earnest after the Centers for Disease Control and Prevention convenes a panel on Tuesday to further discuss clinical recommendations. Pfizer and its partner BioNTech announced this week.
The US government had bought 50 million more doses as it works to protect children, including eventually those under five. In a clinical trial involving more than 2,000 participants was found to be more than 90 percent effective at preventing symptomatic disease. The vaccine's safety was also studied in more than 3,000 children, and no serious side effects have been detected in the ongoing study. In this age group, the vaccine is given as two shots three weeks apart, dosed at 10 micrograms -- a third what is given to older age groups. Severe Covid is rarer in children than adults, but far from non-existent.
According to the CDC, there have been 8,300 Covid hospitalizations of children aged five-to-11 since the start of the pandemic, and 146 deaths. There have also been more than 5,000 pediatric cases of multisystem inflammatory syndrome in children (MIS-C), a rare but highly serious post-viral complication, including 46 deaths. Health authorities will continue to monitor for potentially highly rare side-effects, such as myocarditis and pericarditis (heart inflammation and inflammation around the heart). The clinical trials were too small to detect these, but the hypothesis is they will be exceedingly rare, because the effect is thought linked to testosterone levels.
Microsoft to build a new data centre to support Thailand's tec
Microsoft has revealed intentions to construct a regional data centre as w...
SAP launches cloud services to help Indian scaleups innovate m
SAP at SAP unveils now "GROW with SAP for Scaleups," a new cloud service d...
Denodo and Sonata form alliance to unlock data-to-value creati
Denodo and Sonata Information Technology India Limited (SITL) have annou...
Google Play Store will now let users download two apps simulta
Google Play Store now lets users download two apps simultaneously. While a...
MATRIX COMSEC PVT. LTD.
QUICK HEAL TECHNOLOGIES PVT. Ltd.
OPTIEMUS INFRACOM
JUVAS SOLUTIONS PVT. LTD.
Technology Icons Of India 2023: Sunil Gupta
Sunil Gupta is the Co-founder, Managing Partner & CEO of Yotta Infrast...
Technology Icons Of India 2023: Nandan Nilekani
Nandan Nilekani is the Co-Founder and Chairman of the Board, Infosys T...
Technology Icons Of India 2023: Sachin Bansal
Sachin Bansal’s fintech startup, Navi Technologies, simplifies loan ...
BEL leveraging next generation technologies to keep the country ahead in Defence space
Bharat Electronics Limited (BEL) is a Navratna PSU under the Ministry ...
PGCIL transforming India with its wide power transmission network
Engaged in power transmission, POWERGRID or PGCIL is a stated owned In...
GeM maintains transparency in online procurement of goods & services
Created in a record time of five months, Government eMarketplace is a ...
INTEGRA MICRO SYSTEMS PVT. LTD.
Integra is a leading provider of innovative hi-technology products an...
Crayon Software Experts India Pvt Ltd
Crayon helps its customers build the commercial and technical foundati...
IRIS GLOBAL SERVICES PVT. LTD.
Iris Global services is one of the leading distribution houses that d...